Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2019-06-21 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
关于取得医疗器械注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates from a regulatory authority (Henan Provincial Drug Administration). It details the certificates obtained, product descriptions, R&D investments, similar products in the market, impact on company performance, and risk warnings. The document is short (1450 characters) and is an announcement of a regulatory approval event rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or detailed governance information. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about product registration and compliance.
2019-06-21 Chinese
关于控股子公司完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the completion of a business registration change for a controlling subsidiary of the company. It includes details about the new business license and company information but does not contain financial data, management changes, or regulatory filings beyond the registration update. It is not a full report, financial statement, or meeting material. The content fits best as a general regulatory announcement about corporate changes, which aligns with the Regulatory Filings (RNS) category.
2019-06-13 Chinese
关于取得医疗器械注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration certificate from the National Medical Products Administration. It details the product registration, related R&D investment, market context, and potential impact on company performance. The document is short (1387 characters) and does not contain financial statements or detailed financial data. It is an official announcement about a regulatory approval rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-06-13 Chinese
关于取得医疗器械注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates from a regulatory authority (Henan Provincial Drug Administration). It details the product names, registration numbers, intended uses, and the impact on company performance. There is no financial data, no mention of financial results, no management discussion of financials, no voting results, no share transactions, no legal proceedings, no merger or acquisition activity, and no report publication. The document is a regulatory announcement about product certification and compliance, which does not fit into financial report categories but is a regulatory filing. The document length is 2613 characters, which is short and consistent with an announcement rather than a full report. Therefore, the best classification is Regulatory Filings (RNS).
2019-06-05 Chinese
关于二级子公司完成工商变更登记并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Zhengzhou Antu Biological Engineering Co., Ltd. regarding the completion of industrial and commercial registration changes and obtaining a business license by its secondary subsidiary. It details the share transfer of 51% equity in a subsidiary and the completion of related registration formalities. The document is short (920 characters) and focuses on corporate structural changes and regulatory compliance related to a subsidiary, without financial statements or detailed financial data. It is not a full report, earnings release, or management discussion. It is an announcement about a corporate event related to subsidiary registration and business license acquisition, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-06-05 Chinese
使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a progress announcement regarding the company's use of idle raised funds for cash management, detailing the purchase and redemption of financial products. It includes specific dates and amounts but does not contain comprehensive financial statements or detailed financial analysis. The document is relatively short (1184 characters) and serves as an update on financing activities related to raised funds. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or regulatory filing. Therefore, the appropriate classification is CAP.
2019-06-03 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.